PHIO PHARMACEUTICALS CORP. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
PHIO PHARMACEUTICALS CORP. (PHIO) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $157.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-26.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2018-03-26
- 2017-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $157.00K.
- 2016-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $475.00K.
- 2015-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.20M.
- 2014-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2017-12-31 | $157.00K 10-K · filed 2018-03-26 |
| 2016-12-31 | $475.00K 10-K · filed 2017-03-30 |
| 2015-12-31 | $1.20M 10-K · filed 2016-03-30 |
| 2014-12-31 | $2.70M 10-K · filed 2015-03-30 |
| 2013-12-31 | $3.63M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |